FI64365C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat Download PDF

Info

Publication number
FI64365C
FI64365C FI782847A FI782847A FI64365C FI 64365 C FI64365 C FI 64365C FI 782847 A FI782847 A FI 782847A FI 782847 A FI782847 A FI 782847A FI 64365 C FI64365 C FI 64365C
Authority
FI
Finland
Prior art keywords
therapeutic
methyl
pyridyl
compounds
naphth
Prior art date
Application number
FI782847A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI782847A (fi
FI64365B (fi
Inventor
Anna Krasso
Ernst-Peter Krebs
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI782847A publication Critical patent/FI782847A/fi
Application granted granted Critical
Publication of FI64365B publication Critical patent/FI64365B/fi
Publication of FI64365C publication Critical patent/FI64365C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI782847A 1977-09-19 1978-09-18 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat FI64365C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
LU78140 1977-09-19
CH814978 1978-07-28
CH814978 1978-07-28

Publications (3)

Publication Number Publication Date
FI782847A FI782847A (fi) 1979-03-20
FI64365B FI64365B (fi) 1983-07-29
FI64365C true FI64365C (fi) 1983-11-10

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782847A FI64365C (fi) 1977-09-19 1978-09-18 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat

Country Status (36)

Country Link
US (2) US4182766A (no)
EP (1) EP0001279B1 (no)
JP (1) JPS5459274A (no)
AR (1) AR224350A1 (no)
AT (1) AT368152B (no)
AU (1) AU519711B2 (no)
BG (1) BG28708A3 (no)
BR (1) BR7806148A (no)
CA (1) CA1106849A (no)
DD (1) DD138210A5 (no)
DE (2) DE2861237D1 (no)
DK (1) DK406578A (no)
EG (1) EG13530A (no)
ES (1) ES473451A1 (no)
FI (1) FI64365C (no)
FR (1) FR2403340A1 (no)
GB (1) GB2004281B (no)
GR (1) GR73069B (no)
HU (1) HU176111B (no)
IE (1) IE47363B1 (no)
IL (1) IL55557A (no)
IN (1) IN148930B (no)
IT (1) IT1098858B (no)
MC (1) MC1213A1 (no)
MT (1) MTP835B (no)
NL (1) NL7809529A (no)
NO (1) NO149962C (no)
NZ (1) NZ188405A (no)
OA (1) OA06054A (no)
PH (1) PH16342A (no)
PL (1) PL114494B1 (no)
PT (1) PT68573A (no)
RO (1) RO75258A (no)
SE (1) SE7809792L (no)
SU (1) SU793390A3 (no)
YU (1) YU216778A (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
IL71665A (en) * 1983-05-03 1988-05-31 Byk Gulden Lomberg Chem Fab Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
AU5768886A (en) 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
PL307026A1 (en) * 1992-07-08 1995-05-02 Monsanto Co Method of producing ppaliative effect in respect to swine gastric ulcers
AU2395095A (en) * 1994-04-29 1995-11-29 G.D. Searle & Co. Method of using (h+/k+) atpase inhibitors as antiviral agents
US6207198B1 (en) * 1995-09-21 2001-03-27 Schwarz Pharma Ag Composition containing an acid-labile omeprazole and process for its preparation
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) * 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA06000529A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
EP1648417A4 (en) * 2003-07-18 2010-01-20 Santarus Inc PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (no) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
IT7827861A0 (it) 1978-09-19
JPS5459274A (en) 1979-05-12
NO783155L (no) 1979-03-20
FI782847A (fi) 1979-03-20
ATA673378A (de) 1982-01-15
NO149962B (no) 1984-04-16
IE47363B1 (en) 1984-03-07
EP0001279A1 (de) 1979-04-04
AT368152B (de) 1982-09-27
IT1098858B (it) 1985-09-18
YU216778A (en) 1983-01-21
AU3981778A (en) 1980-03-20
RO75258A (ro) 1980-11-30
DK406578A (da) 1979-03-20
ES473451A1 (es) 1979-05-01
AU519711B2 (en) 1981-12-17
HU176111B (en) 1980-12-28
FI64365B (fi) 1983-07-29
MC1213A1 (fr) 1979-05-18
GB2004281A (en) 1979-03-28
BG28708A3 (en) 1980-06-16
FR2403340B1 (no) 1981-02-13
GB2004281B (en) 1982-03-10
NL7809529A (nl) 1979-03-21
IL55557A (en) 1982-02-28
MTP835B (en) 1979-11-14
BR7806148A (pt) 1979-04-17
GR73069B (no) 1984-01-30
IE781878L (en) 1979-03-19
PH16342A (en) 1983-09-05
PL114494B1 (en) 1981-01-31
SU793390A3 (ru) 1980-12-30
NO149962C (no) 1984-07-25
DE2840591A1 (de) 1979-03-29
PT68573A (fr) 1978-10-01
IN148930B (no) 1981-07-25
US4248880A (en) 1981-02-03
EP0001279B1 (de) 1981-09-30
US4182766A (en) 1980-01-08
PL209693A1 (pl) 1979-06-04
EG13530A (en) 1981-12-31
IL55557A0 (en) 1978-12-17
SE7809792L (sv) 1979-03-20
CA1106849A (en) 1981-08-11
DE2861237D1 (en) 1981-12-10
NZ188405A (en) 1981-03-16
OA06054A (fr) 1981-06-30
FR2403340A1 (fr) 1979-04-13
AR224350A1 (es) 1981-11-30
DD138210A5 (de) 1979-10-17

Similar Documents

Publication Publication Date Title
FI64365C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat
FI87565C (fi) Analogifoerfarande foer framstaellning av antibakteriellt aktiva 6-fluor-7-diazabicykloalkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat
CS203970B2 (en) Method of producing novel heterocyclyl-oxy-hydroxy-amino-propanes
US4560693A (en) [1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles
CZ20011082A3 (cs) Tetrahydropyridoethery
JPH0524917B2 (no)
WO2007073935A1 (en) Heterocyclic compounds
AU2005300733A1 (en) Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
US4083983A (en) Alkoxy pyridine compounds
PL181801B1 (pl) Podstawione aryloalkilotioalkilotiopirydyny do zwalczania bakterii Helicobacter oraz srodek leczniczy zawierajacy podstawione aryloalkilotioalkilotiopirydyny PL
PL151696B1 (en) Method of obtaining derivatives of quinolone
KR100549631B1 (ko) 시아노구아니딘, 이의 제조방법 및 이를 함유하는 약제학적 제제
EP1838696B1 (en) Novel cyanoguanidine compounds
US4154838A (en) Alkoxy pyridine
EP2269988B1 (en) Anthranilic acid amides and pharmaceutical use thereof
CN110256405B (zh) 5-烃基-n-取代芳基吡啶酮衍生物及其制备方法和用途
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
EP0251294B1 (en) Substituted isoquinoline derivatives and anti-ulcer agents
DE60013607T2 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
US4076717A (en) Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US4389403A (en) 1-Aroyl-2-phenylamino-2-imidazolines, drugs containing these compounds, and use thereof
US5114954A (en) Antiinflammatory benzylselenobenzamides from aminopyridines and picolylamines
DE60007748T2 (de) Benzimidazolderivate und sie enthaltende medikamente
DE10238045A1 (de) 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
PL182517B1 (pl) Tiopirydyny do zwalczania bakterii Helicobacter

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CO. AG